nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—RXRB—Vitamin D Metabolism—CYP24A1—multiple sclerosis	0.0348	0.0633	CbGpPWpGaD
Adapalene—RXRB—Vitamin D Metabolism—CYP27B1—multiple sclerosis	0.0348	0.0633	CbGpPWpGaD
Adapalene—Pain of skin—Cladribine—multiple sclerosis	0.0228	0.0707	CcSEcCtD
Adapalene—RXRA—Vitamin D Metabolism—CYP24A1—multiple sclerosis	0.0181	0.033	CbGpPWpGaD
Adapalene—RXRA—Vitamin D Metabolism—CYP27B1—multiple sclerosis	0.0181	0.033	CbGpPWpGaD
Adapalene—Abrasion NOS—Triamcinolone—multiple sclerosis	0.0162	0.0503	CcSEcCtD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0152	0.0276	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0152	0.0276	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0136	0.0248	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0136	0.0248	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0131	0.0238	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0131	0.0238	CbGpPWpGaD
Adapalene—RXRB—Vitamin D Metabolism—VDR—multiple sclerosis	0.0114	0.0207	CbGpPWpGaD
Adapalene—Papilloedema—Prednisolone—multiple sclerosis	0.0091	0.0282	CcSEcCtD
Adapalene—RARG—retina—multiple sclerosis	0.00887	0.0691	CbGeAlD
Adapalene—Excoriation—Triamcinolone—multiple sclerosis	0.00881	0.0274	CcSEcCtD
Adapalene—Papilloedema—Triamcinolone—multiple sclerosis	0.00836	0.026	CcSEcCtD
Adapalene—Papilloedema—Methylprednisolone—multiple sclerosis	0.00835	0.0259	CcSEcCtD
Adapalene—Redness—Cladribine—multiple sclerosis	0.00795	0.0247	CcSEcCtD
Adapalene—RXRG—medulla oblongata—multiple sclerosis	0.00768	0.0598	CbGeAlD
Adapalene—Eczema—Fingolimod—multiple sclerosis	0.00764	0.0237	CcSEcCtD
Adapalene—Eye pain—Fingolimod—multiple sclerosis	0.00761	0.0236	CcSEcCtD
Adapalene—Papilloedema—Dexamethasone—multiple sclerosis	0.00759	0.0236	CcSEcCtD
Adapalene—Papilloedema—Betamethasone—multiple sclerosis	0.00759	0.0236	CcSEcCtD
Adapalene—RXRG—midbrain—multiple sclerosis	0.00702	0.0547	CbGeAlD
Adapalene—RXRG—spinal cord—multiple sclerosis	0.00685	0.0534	CbGeAlD
Adapalene—Papilloedema—Prednisone—multiple sclerosis	0.00661	0.0205	CcSEcCtD
Adapalene—RXRA—nervous system—multiple sclerosis	0.00657	0.0512	CbGeAlD
Adapalene—RARG—Nuclear Receptors—PGR—multiple sclerosis	0.00651	0.0118	CbGpPWpGaD
Adapalene—RXRA—central nervous system—multiple sclerosis	0.00633	0.0493	CbGeAlD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00616	0.0112	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—PGR—multiple sclerosis	0.00595	0.0108	CbGpPWpGaD
Adapalene—RXRA—Vitamin D Metabolism—VDR—multiple sclerosis	0.00593	0.0108	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—PGR—multiple sclerosis	0.00584	0.0106	CbGpPWpGaD
Adapalene—Sunburn—Methotrexate—multiple sclerosis	0.00582	0.0181	CcSEcCtD
Adapalene—RXRG—nervous system—multiple sclerosis	0.00577	0.045	CbGeAlD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00564	0.0103	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—PGR—multiple sclerosis	0.0056	0.0102	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—PGR—multiple sclerosis	0.0056	0.0102	CbGpPWpGaD
Adapalene—RARB—cerebellum—multiple sclerosis	0.00556	0.0433	CbGeAlD
Adapalene—RXRG—central nervous system—multiple sclerosis	0.00556	0.0433	CbGeAlD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00553	0.0101	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.0055	0.01	CbGpPWpGaD
Adapalene—RXRB—nervous system—multiple sclerosis	0.00543	0.0423	CbGeAlD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.0053	0.00964	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.0053	0.00964	CbGpPWpGaD
Adapalene—RXRB—central nervous system—multiple sclerosis	0.00522	0.0407	CbGeAlD
Adapalene—RARG—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00514	0.00936	CbGpPWpGaD
Adapalene—RXRB—cerebellum—multiple sclerosis	0.00511	0.0398	CbGeAlD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00503	0.00914	CbGpPWpGaD
Adapalene—RXRA—brain—multiple sclerosis	0.00502	0.0391	CbGeAlD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00497	0.00905	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00493	0.00897	CbGpPWpGaD
Adapalene—RARG—nervous system—multiple sclerosis	0.00482	0.0375	CbGeAlD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00473	0.0086	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00473	0.0086	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00471	0.00856	CbGpPWpGaD
Adapalene—Optic neuritis—Prednisolone—multiple sclerosis	0.0047	0.0146	CcSEcCtD
Adapalene—RARG—central nervous system—multiple sclerosis	0.00464	0.0361	CbGeAlD
Adapalene—RARB—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00461	0.00839	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—VDR—multiple sclerosis	0.00455	0.00828	CbGpPWpGaD
Adapalene—RARG—cerebellum—multiple sclerosis	0.00453	0.0353	CbGeAlD
Adapalene—RARA—nervous system—multiple sclerosis	0.00453	0.0353	CbGeAlD
Adapalene—RARB—brain—multiple sclerosis	0.00451	0.0352	CbGeAlD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00446	0.00811	CbGpPWpGaD
Adapalene—Keratitis—Prednisolone—multiple sclerosis	0.00446	0.0138	CcSEcCtD
Adapalene—RXRB—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00442	0.00805	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00442	0.00805	CbGpPWpGaD
Adapalene—RXRG—brain—multiple sclerosis	0.00441	0.0344	CbGeAlD
Adapalene—RARA—central nervous system—multiple sclerosis	0.00436	0.034	CbGeAlD
Adapalene—Optic neuritis—Triamcinolone—multiple sclerosis	0.00432	0.0134	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00432	0.00787	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00432	0.00787	CbGpPWpGaD
Adapalene—Optic neuritis—Methylprednisolone—multiple sclerosis	0.00431	0.0134	CcSEcCtD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00428	0.00778	CbGpPWpGaD
Adapalene—RARA—cerebellum—multiple sclerosis	0.00426	0.0332	CbGeAlD
Adapalene—RXRG—Nuclear Receptors—VDR—multiple sclerosis	0.00416	0.00757	CbGpPWpGaD
Adapalene—RXRB—brain—multiple sclerosis	0.00415	0.0323	CbGeAlD
Adapalene—RARB—Nuclear Receptors—VDR—multiple sclerosis	0.00408	0.00742	CbGpPWpGaD
Adapalene—Optic neuritis—Dexamethasone—multiple sclerosis	0.00392	0.0122	CcSEcCtD
Adapalene—Optic neuritis—Betamethasone—multiple sclerosis	0.00392	0.0122	CcSEcCtD
Adapalene—RXRB—Nuclear Receptors—VDR—multiple sclerosis	0.00391	0.00712	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—VDR—multiple sclerosis	0.00391	0.00712	CbGpPWpGaD
Adapalene—Dermatitis atopic—Prednisolone—multiple sclerosis	0.00391	0.0121	CcSEcCtD
Adapalene—Keratitis—Dexamethasone—multiple sclerosis	0.00372	0.0116	CcSEcCtD
Adapalene—Keratitis—Betamethasone—multiple sclerosis	0.00372	0.0116	CcSEcCtD
Adapalene—RARG—brain—multiple sclerosis	0.00368	0.0287	CbGeAlD
Adapalene—RARG—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00359	0.00654	CbGpPWpGaD
Adapalene—Dermatitis atopic—Triamcinolone—multiple sclerosis	0.00359	0.0112	CcSEcCtD
Adapalene—Stinging—Prednisolone—multiple sclerosis	0.00357	0.0111	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00351	0.00638	CbGpPWpGaD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00351	0.00638	CbGpPWpGaD
Adapalene—RARA—brain—multiple sclerosis	0.00346	0.027	CbGeAlD
Adapalene—Optic neuritis—Prednisone—multiple sclerosis	0.00342	0.0106	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00329	0.00598	CbGpPWpGaD
Adapalene—Stinging—Triamcinolone—multiple sclerosis	0.00328	0.0102	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00322	0.00587	CbGpPWpGaD
Adapalene—Herpes simplex—Prednisolone—multiple sclerosis	0.00314	0.00975	CcSEcCtD
Adapalene—RARA—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00309	0.00562	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00309	0.00562	CbGpPWpGaD
Adapalene—Stinging—Dexamethasone—multiple sclerosis	0.00298	0.00925	CcSEcCtD
Adapalene—Stinging—Betamethasone—multiple sclerosis	0.00298	0.00925	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00295	0.00536	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—PGR—multiple sclerosis	0.00292	0.00531	CbGpPWpGaD
Adapalene—Conjunctivitis—Cladribine—multiple sclerosis	0.00292	0.00906	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisone—multiple sclerosis	0.00284	0.00882	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00276	0.00502	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00269	0.0049	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00264	0.00481	CbGpPWpGaD
Adapalene—Dermatitis contact—Triamcinolone—multiple sclerosis	0.00263	0.00816	CcSEcCtD
Adapalene—Herpes simplex—Betamethasone—multiple sclerosis	0.00262	0.00813	CcSEcCtD
Adapalene—Herpes simplex—Dexamethasone—multiple sclerosis	0.00262	0.00813	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.0026	0.00472	CbGpPWpGaD
Adapalene—RXRA—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00255	0.00464	CbGpPWpGaD
Adapalene—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00254	0.00789	CcSEcCtD
Adapalene—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.00253	0.00787	CcSEcCtD
Adapalene—RARA—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00253	0.00461	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00253	0.00461	CbGpPWpGaD
Adapalene—Burning sensation—Methotrexate—multiple sclerosis	0.00253	0.00785	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00249	0.00453	CbGpPWpGaD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—VDR—multiple sclerosis	0.00246	0.00448	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.00244	0.00445	CbGpPWpGaD
Adapalene—Pruritus—Fingolimod—multiple sclerosis	0.00239	0.00742	CcSEcCtD
Adapalene—Dermatitis contact—Betamethasone—multiple sclerosis	0.00239	0.00741	CcSEcCtD
Adapalene—Dermatitis contact—Dexamethasone—multiple sclerosis	0.00239	0.00741	CcSEcCtD
Adapalene—Erythema—Cladribine—multiple sclerosis	0.00234	0.00728	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00231	0.00419	CbGpPWpGaD
Adapalene—Skin exfoliation—Betamethasone—multiple sclerosis	0.0023	0.00716	CcSEcCtD
Adapalene—Skin exfoliation—Dexamethasone—multiple sclerosis	0.0023	0.00716	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00228	0.00415	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.00223	0.00407	CbGpPWpGaD
Adapalene—Dermatitis bullous—Prednisolone—multiple sclerosis	0.0022	0.00682	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.00219	0.00399	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00214	0.00389	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.0021	0.00382	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.0021	0.00382	CbGpPWpGaD
Adapalene—RXRA—Endogenous sterols—POMC—multiple sclerosis	0.00209	0.00381	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00209	0.0038	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00205	0.00372	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—VDR—multiple sclerosis	0.00204	0.00371	CbGpPWpGaD
Adapalene—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00202	0.00627	CcSEcCtD
Adapalene—Skin exfoliation—Prednisone—multiple sclerosis	0.00201	0.00623	CcSEcCtD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00196	0.00357	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00196	0.00357	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00195	0.00356	CbGpPWpGaD
Adapalene—Skin discolouration—Methotrexate—multiple sclerosis	0.00194	0.00604	CcSEcCtD
Adapalene—Eye pain—Dexamethasone—multiple sclerosis	0.00194	0.00603	CcSEcCtD
Adapalene—Eye pain—Betamethasone—multiple sclerosis	0.00194	0.00603	CcSEcCtD
Adapalene—Dry skin—Prednisolone—multiple sclerosis	0.00192	0.00598	CcSEcCtD
Adapalene—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.00192	0.00595	CcSEcCtD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00192	0.00349	CbGpPWpGaD
Adapalene—Herpes simplex—Methotrexate—multiple sclerosis	0.00191	0.00592	CcSEcCtD
Adapalene—RXRA—Biological oxidations—CYP27B1—multiple sclerosis	0.00186	0.00339	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP24A1—multiple sclerosis	0.00186	0.00339	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00184	0.00334	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.00184	0.00334	CbGpPWpGaD
Adapalene—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00183	0.00569	CcSEcCtD
Adapalene—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00183	0.00569	CcSEcCtD
Adapalene—Hepatitis—Mitoxantrone—multiple sclerosis	0.00177	0.0055	CcSEcCtD
Adapalene—Skin exfoliation—Methotrexate—multiple sclerosis	0.00168	0.00521	CcSEcCtD
Adapalene—Pain—Cladribine—multiple sclerosis	0.00164	0.00508	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00161	0.00293	CbGpPWpGaD
Adapalene—Dry skin—Betamethasone—multiple sclerosis	0.00161	0.00499	CcSEcCtD
Adapalene—Dry skin—Dexamethasone—multiple sclerosis	0.00161	0.00499	CcSEcCtD
Adapalene—RARG—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.0016	0.00291	CbGpPWpGaD
Adapalene—Conjunctivitis—Prednisolone—multiple sclerosis	0.00157	0.00488	CcSEcCtD
Adapalene—Erythema—Mitoxantrone—multiple sclerosis	0.00154	0.00479	CcSEcCtD
Adapalene—Urticaria—Cladribine—multiple sclerosis	0.00152	0.00472	CcSEcCtD
Adapalene—Face oedema—Prednisone—multiple sclerosis	0.00147	0.00457	CcSEcCtD
Adapalene—RXRG—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.00147	0.00267	CbGpPWpGaD
Adapalene—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00145	0.00449	CcSEcCtD
Adapalene—RARB—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.00144	0.00261	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.00142	0.00259	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ZNF746—multiple sclerosis	0.00142	0.00258	CbGpPWpGaD
Adapalene—Hypersensitivity—Cladribine—multiple sclerosis	0.00141	0.00438	CcSEcCtD
Adapalene—Dry skin—Prednisone—multiple sclerosis	0.0014	0.00434	CcSEcCtD
Adapalene—RXRA—Developmental Biology—CD24—multiple sclerosis	0.00139	0.00254	CbGpPWpGaD
Adapalene—RARA—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.00138	0.00251	CbGpPWpGaD
Adapalene—RXRB—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.00138	0.00251	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.00136	0.00248	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—FAS—multiple sclerosis	0.00136	0.00247	CbGpPWpGaD
Adapalene—Pruritus—Cladribine—multiple sclerosis	0.00135	0.0042	CcSEcCtD
Adapalene—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.00135	0.0042	CcSEcCtD
Adapalene—Convulsion—Mitoxantrone—multiple sclerosis	0.00134	0.00415	CcSEcCtD
Adapalene—RXRA—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.00133	0.00243	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00132	0.0024	CbGpPWpGaD
Adapalene—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00131	0.00408	CcSEcCtD
Adapalene—Conjunctivitis—Betamethasone—multiple sclerosis	0.00131	0.00408	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.0013	0.00236	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PTBP1—multiple sclerosis	0.0013	0.00236	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ZNF746—multiple sclerosis	0.0013	0.00236	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—FAS—multiple sclerosis	0.00128	0.00232	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ZNF746—multiple sclerosis	0.00127	0.00231	CbGpPWpGaD
Adapalene—Erythema—Prednisolone—multiple sclerosis	0.00126	0.00393	CcSEcCtD
Adapalene—RARA—Gene Expression—ZNF746—multiple sclerosis	0.00122	0.00222	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ZNF746—multiple sclerosis	0.00122	0.00222	CbGpPWpGaD
Adapalene—Rash—Cladribine—multiple sclerosis	0.00121	0.00375	CcSEcCtD
Adapalene—Dermatitis—Cladribine—multiple sclerosis	0.00121	0.00374	CcSEcCtD
Adapalene—RXRG—Gene Expression—PTBP1—multiple sclerosis	0.00119	0.00216	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	0.00117	0.00213	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PTBP1—multiple sclerosis	0.00116	0.00212	CbGpPWpGaD
Adapalene—Erythema—Triamcinolone—multiple sclerosis	0.00116	0.00361	CcSEcCtD
Adapalene—Erythema—Methylprednisolone—multiple sclerosis	0.00116	0.0036	CcSEcCtD
Adapalene—Angioedema—Prednisolone—multiple sclerosis	0.00116	0.00359	CcSEcCtD
Adapalene—Hypersensitivity—Azathioprine—multiple sclerosis	0.00115	0.00356	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.00114	0.00208	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PTBP1—multiple sclerosis	0.00112	0.00203	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PTBP1—multiple sclerosis	0.00112	0.00203	CbGpPWpGaD
Adapalene—RXRA—PPAR Alpha Pathway—MYC—multiple sclerosis	0.0011	0.002	CbGpPWpGaD
Adapalene—Convulsion—Prednisolone—multiple sclerosis	0.0011	0.0034	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.0011	0.00199	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.00109	0.00199	CbGpPWpGaD
Adapalene—Pain—Mitoxantrone—multiple sclerosis	0.00108	0.00334	CcSEcCtD
Adapalene—Angioedema—Triamcinolone—multiple sclerosis	0.00106	0.0033	CcSEcCtD
Adapalene—Angioedema—Methylprednisolone—multiple sclerosis	0.00106	0.00329	CcSEcCtD
Adapalene—Erythema—Betamethasone—multiple sclerosis	0.00106	0.00328	CcSEcCtD
Adapalene—Erythema—Dexamethasone—multiple sclerosis	0.00106	0.00328	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.00102	0.00186	CbGpPWpGaD
Adapalene—Convulsion—Triamcinolone—multiple sclerosis	0.00101	0.00313	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00101	0.00312	CcSEcCtD
Adapalene—Convulsion—Methylprednisolone—multiple sclerosis	0.00101	0.00312	CcSEcCtD
Adapalene—Urticaria—Mitoxantrone—multiple sclerosis	0.000999	0.0031	CcSEcCtD
Adapalene—RARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000983	0.00179	CbGpPWpGaD
Adapalene—RARG—Gene Expression—U2AF2—multiple sclerosis	0.000983	0.00179	CbGpPWpGaD
Adapalene—Rash—Azathioprine—multiple sclerosis	0.000981	0.00305	CcSEcCtD
Adapalene—Dermatitis—Azathioprine—multiple sclerosis	0.00098	0.00304	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000978	0.00178	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000973	0.00177	CbGpPWpGaD
Adapalene—Angioedema—Betamethasone—multiple sclerosis	0.000964	0.00299	CcSEcCtD
Adapalene—Angioedema—Dexamethasone—multiple sclerosis	0.000964	0.00299	CcSEcCtD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.000958	0.00174	CbGpPWpGaD
Adapalene—Conjunctivitis—Methotrexate—multiple sclerosis	0.000955	0.00297	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.000943	0.00172	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000937	0.00171	CbGpPWpGaD
Adapalene—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000927	0.00288	CcSEcCtD
Adapalene—Erythema—Prednisone—multiple sclerosis	0.000919	0.00285	CcSEcCtD
Adapalene—Convulsion—Betamethasone—multiple sclerosis	0.000914	0.00284	CcSEcCtD
Adapalene—Convulsion—Dexamethasone—multiple sclerosis	0.000914	0.00284	CcSEcCtD
Adapalene—RXRG—Gene Expression—U2AF2—multiple sclerosis	0.000899	0.00164	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—HNRNPA1—multiple sclerosis	0.000899	0.00164	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000889	0.00162	CbGpPWpGaD
Adapalene—Pain—Prednisolone—multiple sclerosis	0.000882	0.00274	CcSEcCtD
Adapalene—Hepatitis—Methotrexate—multiple sclerosis	0.000882	0.00274	CcSEcCtD
Adapalene—RARB—Gene Expression—U2AF2—multiple sclerosis	0.000882	0.0016	CbGpPWpGaD
Adapalene—RARB—Gene Expression—HNRNPA1—multiple sclerosis	0.000882	0.0016	CbGpPWpGaD
Adapalene—RARA—Gene Expression—U2AF2—multiple sclerosis	0.000845	0.00154	CbGpPWpGaD
Adapalene—RARA—Gene Expression—HNRNPA1—multiple sclerosis	0.000845	0.00154	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—U2AF2—multiple sclerosis	0.000845	0.00154	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—HNRNPA1—multiple sclerosis	0.000845	0.00154	CbGpPWpGaD
Adapalene—Angioedema—Prednisone—multiple sclerosis	0.00084	0.00261	CcSEcCtD
Adapalene—Urticaria—Prednisolone—multiple sclerosis	0.00082	0.00255	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000813	0.00148	CbGpPWpGaD
Adapalene—Pain—Triamcinolone—multiple sclerosis	0.000811	0.00252	CcSEcCtD
Adapalene—RARB—Generic Transcription Pathway—PGR—multiple sclerosis	0.000797	0.00145	CbGpPWpGaD
Adapalene—Convulsion—Prednisone—multiple sclerosis	0.000796	0.00247	CcSEcCtD
Adapalene—Rash—Mitoxantrone—multiple sclerosis	0.000793	0.00246	CcSEcCtD
Adapalene—Dermatitis—Mitoxantrone—multiple sclerosis	0.000792	0.00246	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000788	0.00143	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ZFP36L1—multiple sclerosis	0.000777	0.00141	CbGpPWpGaD
Adapalene—Erythema—Methotrexate—multiple sclerosis	0.000768	0.00238	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—PGR—multiple sclerosis	0.000764	0.00139	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000764	0.00139	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisolone—multiple sclerosis	0.00076	0.00236	CcSEcCtD
Adapalene—Urticaria—Triamcinolone—multiple sclerosis	0.000754	0.00234	CcSEcCtD
Adapalene—Urticaria—Methylprednisolone—multiple sclerosis	0.000752	0.00234	CcSEcCtD
Adapalene—Pain—Dexamethasone—multiple sclerosis	0.000736	0.00229	CcSEcCtD
Adapalene—Pain—Betamethasone—multiple sclerosis	0.000736	0.00229	CcSEcCtD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000731	0.00133	CbGpPWpGaD
Adapalene—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000718	0.00131	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000715	0.0013	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000715	0.0013	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000711	0.00129	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ZFP36L1—multiple sclerosis	0.000711	0.00129	CbGpPWpGaD
Adapalene—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000699	0.00217	CcSEcCtD
Adapalene—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000698	0.00217	CcSEcCtD
Adapalene—RARB—Gene Expression—ZFP36L1—multiple sclerosis	0.000697	0.00127	CbGpPWpGaD
Adapalene—Urticaria—Dexamethasone—multiple sclerosis	0.000684	0.00212	CcSEcCtD
Adapalene—Urticaria—Betamethasone—multiple sclerosis	0.000684	0.00212	CcSEcCtD
Adapalene—Pruritus—Triamcinolone—multiple sclerosis	0.000671	0.00208	CcSEcCtD
Adapalene—Pruritus—Methylprednisolone—multiple sclerosis	0.00067	0.00208	CcSEcCtD
Adapalene—RARA—Gene Expression—ZFP36L1—multiple sclerosis	0.000668	0.00122	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ZFP36L1—multiple sclerosis	0.000668	0.00122	CbGpPWpGaD
Adapalene—Convulsion—Methotrexate—multiple sclerosis	0.000665	0.00207	CcSEcCtD
Adapalene—RXRG—Adipogenesis—STAT3—multiple sclerosis	0.000665	0.00121	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—FAS—multiple sclerosis	0.000665	0.00121	CbGpPWpGaD
Adapalene—Rash—Prednisolone—multiple sclerosis	0.000651	0.00202	CcSEcCtD
Adapalene—Dermatitis—Prednisolone—multiple sclerosis	0.00065	0.00202	CcSEcCtD
Adapalene—RXRA—Gene Expression—ZNF746—multiple sclerosis	0.000635	0.00116	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—STAT3—multiple sclerosis	0.000625	0.00114	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000621	0.00113	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TGFB1—multiple sclerosis	0.000617	0.00112	CbGpPWpGaD
Adapalene—Pruritus—Dexamethasone—multiple sclerosis	0.000609	0.00189	CcSEcCtD
Adapalene—Pruritus—Betamethasone—multiple sclerosis	0.000609	0.00189	CcSEcCtD
Adapalene—RARG—Gene Expression—PABPC1—multiple sclerosis	0.000602	0.0011	CbGpPWpGaD
Adapalene—Rash—Triamcinolone—multiple sclerosis	0.000598	0.00186	CcSEcCtD
Adapalene—Dermatitis—Triamcinolone—multiple sclerosis	0.000598	0.00186	CcSEcCtD
Adapalene—Rash—Methylprednisolone—multiple sclerosis	0.000597	0.00185	CcSEcCtD
Adapalene—Dermatitis—Methylprednisolone—multiple sclerosis	0.000596	0.00185	CcSEcCtD
Adapalene—Urticaria—Prednisone—multiple sclerosis	0.000596	0.00185	CcSEcCtD
Adapalene—RXRA—Gene Expression—PTBP1—multiple sclerosis	0.000581	0.00106	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TGFB1—multiple sclerosis	0.00058	0.00105	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TNF—multiple sclerosis	0.000576	0.00105	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000571	0.00104	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000568	0.00103	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—VDR—multiple sclerosis	0.000557	0.00101	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000554	0.00101	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisone—multiple sclerosis	0.000552	0.00172	CcSEcCtD
Adapalene—RXRG—Gene Expression—PABPC1—multiple sclerosis	0.000551	0.001	CbGpPWpGaD
Adapalene—RARG—Gene Expression—RPL5—multiple sclerosis	0.000543	0.000989	CbGpPWpGaD
Adapalene—Rash—Betamethasone—multiple sclerosis	0.000543	0.00169	CcSEcCtD
Adapalene—Rash—Dexamethasone—multiple sclerosis	0.000543	0.00169	CcSEcCtD
Adapalene—Dermatitis—Betamethasone—multiple sclerosis	0.000542	0.00168	CcSEcCtD
Adapalene—Dermatitis—Dexamethasone—multiple sclerosis	0.000542	0.00168	CcSEcCtD
Adapalene—RARA—Adipogenesis—TNF—multiple sclerosis	0.000541	0.000985	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PABPC1—multiple sclerosis	0.00054	0.000983	CbGpPWpGaD
Adapalene—Pain—Methotrexate—multiple sclerosis	0.000536	0.00166	CcSEcCtD
Adapalene—RARA—Generic Transcription Pathway—VDR—multiple sclerosis	0.000534	0.000971	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—VDR—multiple sclerosis	0.000534	0.000971	CbGpPWpGaD
Adapalene—Pruritus—Prednisone—multiple sclerosis	0.000531	0.00165	CcSEcCtD
Adapalene—RXRB—Gene Expression—PABPC1—multiple sclerosis	0.000518	0.000942	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PABPC1—multiple sclerosis	0.000518	0.000942	CbGpPWpGaD
Adapalene—Urticaria—Methotrexate—multiple sclerosis	0.000498	0.00155	CcSEcCtD
Adapalene—RXRG—Gene Expression—RPL5—multiple sclerosis	0.000497	0.000904	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000488	0.000889	CbGpPWpGaD
Adapalene—RARB—Gene Expression—RPL5—multiple sclerosis	0.000487	0.000887	CbGpPWpGaD
Adapalene—Rash—Prednisone—multiple sclerosis	0.000473	0.00147	CcSEcCtD
Adapalene—Dermatitis—Prednisone—multiple sclerosis	0.000472	0.00147	CcSEcCtD
Adapalene—RXRB—Gene Expression—RPL5—multiple sclerosis	0.000467	0.00085	CbGpPWpGaD
Adapalene—RARA—Gene Expression—RPL5—multiple sclerosis	0.000467	0.00085	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IL6—multiple sclerosis	0.000465	0.000845	CbGpPWpGaD
Adapalene—Hypersensitivity—Methotrexate—multiple sclerosis	0.000462	0.00143	CcSEcCtD
Adapalene—RXRA—Developmental Biology—PRNP—multiple sclerosis	0.00046	0.000837	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000459	0.000836	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SRM—multiple sclerosis	0.000452	0.000822	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000446	0.000811	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000445	0.000809	CbGpPWpGaD
Adapalene—Pruritus—Methotrexate—multiple sclerosis	0.000443	0.00138	CcSEcCtD
Adapalene—RXRA—Gene Expression—HNRNPA1—multiple sclerosis	0.00044	0.000801	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—U2AF2—multiple sclerosis	0.00044	0.000801	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000438	0.000797	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—IL6—multiple sclerosis	0.000437	0.000795	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000436	0.000793	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000429	0.00078	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PGR—multiple sclerosis	0.000428	0.000778	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000427	0.000777	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000426	0.000775	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—POMC—multiple sclerosis	0.000419	0.000762	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000418	0.00076	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000415	0.000755	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000398	0.000724	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000398	0.000724	CbGpPWpGaD
Adapalene—Rash—Methotrexate—multiple sclerosis	0.000395	0.00123	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—multiple sclerosis	0.000395	0.00123	CcSEcCtD
Adapalene—RXRG—Gene Expression—PGR—multiple sclerosis	0.000391	0.000712	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000387	0.000705	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PGR—multiple sclerosis	0.000384	0.000698	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PGR—multiple sclerosis	0.000368	0.000669	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PGR—multiple sclerosis	0.000368	0.000669	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PTPRC—multiple sclerosis	0.000358	0.000651	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ZFP36L1—multiple sclerosis	0.000348	0.000633	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—STAT3—multiple sclerosis	0.000326	0.000593	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP27B1—multiple sclerosis	0.000318	0.000579	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP24A1—multiple sclerosis	0.000318	0.000579	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000311	0.000566	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TGFB1—multiple sclerosis	0.000302	0.00055	CbGpPWpGaD
Adapalene—RARG—Gene Expression—VDR—multiple sclerosis	0.000299	0.000544	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GPC5—multiple sclerosis	0.000291	0.00053	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—multiple sclerosis	0.000282	0.000513	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—VDR—multiple sclerosis	0.000278	0.000506	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFB1—multiple sclerosis	0.000275	0.000501	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—VDR—multiple sclerosis	0.000273	0.000497	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PABPC1—multiple sclerosis	0.00027	0.000491	CbGpPWpGaD
Adapalene—RARB—Gene Expression—VDR—multiple sclerosis	0.000268	0.000488	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—VDR—multiple sclerosis	0.000257	0.000468	CbGpPWpGaD
Adapalene—RARA—Gene Expression—VDR—multiple sclerosis	0.000257	0.000468	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—multiple sclerosis	0.000247	0.000449	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPL5—multiple sclerosis	0.000244	0.000443	CbGpPWpGaD
Adapalene—RXRA—Metabolism—RRM1—multiple sclerosis	0.000241	0.000439	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—multiple sclerosis	0.000228	0.000414	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MYC—multiple sclerosis	0.000226	0.000411	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000223	0.000405	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000222	0.000404	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—multiple sclerosis	0.000221	0.000403	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000218	0.000396	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—multiple sclerosis	0.000212	0.000386	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—multiple sclerosis	0.000212	0.000386	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000207	0.000377	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PGR—multiple sclerosis	0.000192	0.000349	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000187	0.000341	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000161	0.000293	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TYK2—multiple sclerosis	0.00016	0.000291	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000147	0.000267	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000139	0.000254	CbGpPWpGaD
Adapalene—RXRA—Metabolism—BCHE—multiple sclerosis	0.000139	0.000252	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—VDR—multiple sclerosis	0.000134	0.000244	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP9—multiple sclerosis	0.000126	0.000229	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—multiple sclerosis	0.000119	0.000216	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—STAT3—multiple sclerosis	0.000112	0.000204	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—multiple sclerosis	0.000111	0.000201	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—multiple sclerosis	0.000109	0.000198	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—multiple sclerosis	0.000107	0.000194	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TGFB1—multiple sclerosis	0.000104	0.000189	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—multiple sclerosis	0.000102	0.000186	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—multiple sclerosis	0.000102	0.000186	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAPK1—multiple sclerosis	0.000102	0.000185	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—multiple sclerosis	9.7e-05	0.000176	CbGpPWpGaD
Adapalene—RXRA—Metabolism—APOE—multiple sclerosis	8.34e-05	0.000152	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—multiple sclerosis	7.83e-05	0.000142	CbGpPWpGaD
Adapalene—RXRA—Metabolism—POMC—multiple sclerosis	7.16e-05	0.00013	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALB—multiple sclerosis	6.53e-05	0.000119	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—multiple sclerosis	5.32e-05	9.69e-05	CbGpPWpGaD
